In vitro evaluations of konjac glucomannan and xanthan gum mixture as the sustained release material of matrix tablet

被引:77
作者
Fan, Jiangyang [1 ]
Wang, Kang [1 ]
Liu, Meimei [1 ]
He, Zhimin [1 ]
机构
[1] Tianjin Univ, Sch Chem Engn & Technol, Chem Engn Res Ctr, Enzyme Technol Lab, Tianjin 300072, Peoples R China
关键词
konjac glucomannan; xanthan gum; sustained release matrix tablet; synergistic interaction;
D O I
10.1016/j.carbpol.2007.11.027
中图分类号
O69 [应用化学];
学科分类号
081704 [应用化学];
摘要
The objective of the present investigations was to develop sustained release matrix tablets with a mixture of the polysaccharides, konjac glucomannan (KGM) and xanthan gum (XG), as the sustained release material. A simple enzymatic procedure was selected to mimic the environment of colon in vitro assessments. The concentration of P-mannanase solution in mimic colon media was determined by comparing the hydrolytic ability of the mimic colon solution with that of 4% (w/v) rat cecal content media. In vitro, investigations were carried out to characterize the drug release process. The model drug cimetidine released from polysaccharides gel layer of matrix tablets over 10 h. It was shown that the synergistic interaction between konjac glucomannan and xanthan gum in the gel phase affects on the drug diffusion, which can effectively retard the drug release from the matrix tablets. Further research on the mixed polysaccharides indicated that there was a strong synergistic interaction between KGM and XG in solution and in the gel phase. The experimental results predicted that the polysaccharide mixtures of konjac glucomannan and xanthan gum has a good potential to be applied to sustained release drug delivery systems. (C) 2007 Elsevier Ltd. All rights reserved.
引用
收藏
页码:241 / 247
页数:7
相关论文
共 25 条
[1]
INTERACTION IN XANTHAN-GLUCOMANNAN MIXTURES AND THE INFLUENCE OF ELECTROLYTE [J].
ANNABLE, P ;
WILLIAMS, PA ;
NISHINARI, K .
MACROMOLECULES, 1994, 27 (15) :4204-4211
[2]
A novel enzymatic technique for limiting drug mobility in a hydrogel matrix [J].
Burke, MD ;
Park, JO ;
Srinivasarao, M ;
Khan, SA .
JOURNAL OF CONTROLLED RELEASE, 2005, 104 (01) :141-153
[3]
CLINICAL IMPROVEMENT IN ADVANCED CANCER DISEASE AFTER TREATMENT COMBINING HISTAMINE AND H2-ANTIHISTAMINICS (RANITIDINE OR CIMETIDINE) [J].
BURTIN, C ;
NOIROT, C ;
SCHEINMANN, P ;
GALOPPIN, L ;
SABOLOVIC, D ;
BERNARD, P .
EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1988, 24 (02) :161-167
[4]
Synthesis and properties of degradable hydrogels of konjac glucomannan grafted acrylic acid for colon-specific drug delivery [J].
Chen, LG ;
Liu, ZL ;
Zhuo, RX .
POLYMER, 2005, 46 (16) :6274-6281
[5]
Liquid crystalline, rheological and thermal properties of konjac glucomannan [J].
Dave, V ;
Sheth, M ;
McCarthy, SP ;
Ratto, JA ;
Kaplan, DL .
POLYMER, 1998, 39 (05) :1139-1148
[6]
Optimization of agitation, aeration, and temperature conditions for maximum β-mannanase production [J].
Feng, YY ;
He, ZM ;
Ong, SL ;
Hu, JY ;
Zhang, ZG ;
Ng, WJ .
ENZYME AND MICROBIAL TECHNOLOGY, 2003, 32 (02) :282-289
[7]
CIMETIDINE .1. DEVELOPMENTS, PHARMACOLOGY, AND EFFICACY [J].
FRESTON, JW .
ANNALS OF INTERNAL MEDICINE, 1982, 97 (04) :573-580
[8]
Phosphated crosslinked guar for colon-specific drug delivery II. In vitro and in vivo evaluation in the rat [J].
Gliko-Kabir, I ;
Yagen, B ;
Baluom, M ;
Rubinstein, A .
JOURNAL OF CONTROLLED RELEASE, 2000, 63 (1-2) :129-134
[9]
STOICHIOMETRY AND CONFORMATION OF XANTHAN IN SYNERGISTIC GELATION WITH LOCUST BEAN GUM OR KONJAC GLUCOMANNAN - EVIDENCE FOR HETEROTYPIC BINDING [J].
GOYCOOLEA, FM ;
RICHARDSON, RK ;
MORRIS, ER ;
GIDLEY, MJ .
MACROMOLECULES, 1995, 28 (24) :8308-8320
[10]
A kinetic correlation for konjac powder hydrolysis by β-mannanase from Bacillus licheniformis [J].
He, ZM ;
Zhang, J ;
Huang, DP .
BIOTECHNOLOGY LETTERS, 2001, 23 (05) :389-393